The Factors of growth and aging in physiological senility and in Alzheimer's disease;Los factores de crecimiento y envejecimiento en la senilidad fisiologica yen la enfermedad de Alzheimer

Revista de Neurologia

Volumn 25, Issue 146, 1997, Pages 1592-1602

  Toledano, A ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Ageing factors; Alzheimer's disease; Growth factors

Indexed keywords

AMYLOID; BRAIN DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; NERVE GROWTH FACTOR;

AGING; ALZHEIMER DISEASE; APOPTOSIS; BRAIN ATROPHY; BRAIN MATURATION; BRAIN MITOCHONDRION; CELL SURVIVAL; GROWTH REGULATION; HUMAN; NERVE CELL PLASTICITY; REVIEW; SENESCENCE; SENILITY;

AGED; AGING; ALZHEIMER DISEASE; ATROPHY; BRAIN; GROWTH SUBSTANCES; HUMANS; NECROSIS; NEURONAL PLASTICITY;

EID: 0030665462     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Coyle JT, Price DL, Delong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1993; 219: 1184-90.
2. Iraizoz I, de Lacalle S, Gonzalo LM. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Neuroscience 1991; 41: 33-40.
3. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypotesis of geriatric memory dysfunction. Science 1982; 217: 408-17.
4. Perry EK, Johnson M, Kerwin JM, Piggott MA, Court JA, Shaw PJ, et al. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol Aging 1992; 13: 393-400.
5. Toledano A. Hypotesis concerning the aetiology of Alzheimer's disease. Pharmacopsychiatry 1988; 21: 17-25.
6. De Lacalle S, Iraizoz I, Gonzalo LM. Differential changes in cell size and number in topographical subdivisions of human basal nucleus in normal aging. Neuroscience 1991; 43: 445-6.
7. Peter A, Leahu D, Moss MB, MacNally KJ. The effects of aging on area 46 of the frontal cortex of the rhesus monkey. Cereb Cortex 1994; 4: 621-35.
8. Zoli M, Ferroguti F, Toffano G, Fuxe K, Agnati LF. Neurochemical alterations but not nerve cell loss in aged rat neostriatum. J Chem Neuroanat 1993; 6: 131-45.
9. Toledano A, Barca MA, Moradillo I, Rivas L. Mitochondrial dehydrogenases during senescence of the cerebellar cortex. A comparative electron microscope study. Cell Molec Biol 1988; 34: 175-89.
10. Petruzzella V, Fracasso F, Gadaleta MN, Cantatore P. Age dependen structural variations in rat brain mitochondria. Ann N Y Acad Sci 1992; 673: 194-9.
11. Agnati LF, Fuxe K. Computer assisted morphometry and microdensiometry of transmitter identified neurons with special reference to the mesostriatal dopamine pathway. III Studies on aging process. Acta Physiol Scand 1984; (Suppl 532): 45-61.
12. Toledano A, Rivas L, Rodríguez-Arellano JJ. Morphological and histochemical characteristics of mitochondria during senile involution of the cerebellar cortex. Bull Molec Biol Med 1993; 18: 1-23.
13. Toledano A. Mitochondria, brain aging and degenerative disorders. Aging Clin Exp Res 1993; 5: 459-61.
14. Honer WG, Dickson DW, Gleeson J, Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging 1993; 13: 375-82.
15. Glick R, Bondareff W. Loss of synapses in the cerebellar cortex of the senecent rat. J Gerontol 1979; 34: 818-22.
16. Yufu F, Egashira T, Yamanaka Y. Age-releated changes of cholinergic markers in the rat brain. Jpn J Pharmacol 1994; 66: 247-55.
17. Meana JJ, Barturen F, Garro MA, García-Sevilla JA, Fontan A, Zarranz JJ. Decreased density of presynaptyc alpha-2 adrenoreceptors in post mortem brains of patients with Alzheimer's disease. J Neurochem 1992; 58: 1896-904.
18. Buell SJ, Coleman PD. Quantitative evidence for selective dendritic growth in normal human aging but not senile dementia. Brain Res 1981; 214: 23-41.
19. Bertoni-Freddari C, Fattoretti P, Casoli T, Spagna C, Meier-Ruge W, Ulrich J. Compensatory enlargement of synaptic size in aging and senile dementia. Boll Soc Ital Biol 1993; 69: 57-63.
20. Hefti F, Hartikka J, Krusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol Aging 1989; 10: 515-33.
21. Hefti F, Lapchak PA, Denton TL. Growth factors and neutrophic factors in neurodegenerative disease. In Khachaturian ZK, Blass JP, eds. Alzheimer's disease. New treatment strategies. NEW York: Marcel Dekker; 1992. p. 87-101.
22. Khachaturian Z. The five five, ten ten program to defeat Alzheimer's disease. Neurobiol Aging 1992; 13: 197-8.
23. Toledano A, Díaz MG. Receptores y comunicación celular. Citología 1988; 10: 195-214.
24. Toledano A, Díaz MG. Los segundos mensajeros y la fase intracelular de la comunicación celular. II. Función de los segundos mensajeros. Citología 1992; 12: 23-40.
25. Martín-Zanca D. Factores de crecimiento, receptores y oncogenes. En Cascales M, Villanueva JR, eds. Proliferación celular y cáncer. Madrid: Real Academia de Farmacia/Fundación Cientifica de la Asociación Española contra el Cáncer; 1994. p. 39-121.
26. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375-87.
27. Cohen SR, Levi-Montalcini R, Hamburger V. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc Nat Acad Sci 1954; 40: 1014-24.
28. Persson H, Ibáñez CF. Role and expression of neurotrophins and the trk family of tyrosine kinase receptors in neural growth and rescue after injury. Curr Opin Neurol Neurosurg 1993; 6: 11-8.
29. Ulbrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990; 61: 203-12.
30. Schubert D. Collaborative interactions between growth factors and the extracellular matrix. Trends Cell Biol 1992; 2: 63-6.
31. Hurwitz AA, Lyman WD, Guida MP, Calderón TM, Berman JW. Tumor necrosis factor-alpha induces adhesion molecule expression and human fetal astrocites. J Exp Med 1992; 176: 1631-6.
32. Kononen J, Hökfelt T, Pelto-Huikko M. Effects of ageing on the expression af neurotrophins and their receptors in the rat pituitary grand. Neuroreport 1995; 6: 2430-3.
33. Martín-Pérez J. Protein quinasas: productos de oncogenes en el citoplasma. En Cascales M, Villanueva JR, eds. Proliferación celular y cancer. Madrid: Real Academia de Farmacia/Fundación Cientifica de la Asociación Española contra el Cáncer; 1994. p. 149-75.
34. Bascá L. Transducción de señales y mensajeros intracelulares. En Cascales M, Villanueva JR, eds. Proliferación celular y cáncer. Madrid: Real Academia de Farmacia/Fundación Cientifica de la Asociación Española contra el Cáncer; 1994. p. 123-47.
35. Cross M, Dexter TM. Growth factors in development, transformation and tumorigenesis. Cell 1991; 64: 271-80.
36. Weinberg RA. Growth factors and oncogenes. In Weinberg RA, eds. Oncogenes and molecular origins of cancer. New York: Cold Spring Harbor Laboratory Press; 1989. p. 45-66.
37. Levi-Montalcini R. The nerve growth factor: Thirty-five years later. Science 1987; 237: 1154-64.
38. Levi-Montalcini R, Aloe L, Alleva E. A role for nerve growth factor in nervous, endocrine and immune system. Prog Neuroen Immunol 1990; 3: 1-10.
39. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions-implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703-18.
40. Schreiber SS, Bandry M. Selective neuronal vulnerability in the hippocampus: A role for gene expression? Trends Neurosci 1995; 18: 446-51.
41. Stichel CC, Müller HW. Regenerative failure in the mammalion CNS. Trends Neurosci 1995; 18: 128.
42. Frisen J, Verge VMK, Cullheim S, Persson H, Fried K, Middlemas DS, et al. Increased levels of trk B messenger RNA and trk B protein-like immunoreactivity in the injuried rat and cat spinal cord. Proc Nat Acad Sci 1992; 89: 11282-6.
43. Svendsen CN, Rosser AE. Neurones from stem cells? Trends Neurosci 1995; 18: 465-7.
44. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci 1996; 19: 13-8.
45. Barthel F, Boutillier AL, Trouslard J, Loeffler JPh. Fine tuning of calcium entry into neurons regulates adenosine 3′,5′-monophosphate-dependent transcription by several distinct mechanisms. Neuroscience 1996; 70: 1053-65.
46. Lundquist S, Graing EA. The heat-shock proteins. Ann Rev Genet 1988; 22: 631-7.
47. Mayer J, Brown I, eds. Heat shock proteins in the nervous system. Neuroscience perspectives. New York, London: Academic Press; 1994.
48. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: Actions and mechanisms of action. Trends Neurosci 1995; 18: 130-6.
49. Laim, Sirimanne E, Willians CE, Gluskman PD. Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain. Neuroscience 1996; 70: 1013-24.
50. Prelin JH, Backhanss C, Krieglestein J. Transforming growth factor beta-1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab 1993; 13: 521-5.
51. Robinson LJ, Leitner W, Draznin B, Heidenrich KA. Evidence that p21 ras mediates the neurotrophic effects of insulin and insulin-like growth factor I in chick forebrain neurons. Endocrinology 1994; 135: 2568-73.
52. Baskin DG, Wilcose BJ, Figlewicz DP, Dorsa DM. Insulin and insulin-like growth factors in the CNS. Trends Neurosci 1988; 11: 608-12.
53. Chiarugi VP, Ruggiero M, Carradeth R. Oncogenes, protein kinase C, neuronal differentiation and memory. Neurochem Int 1992; 14: 1-9.
54. Robertson HA. Immediate-early genes, neuronal plasticity and memory. Biochem Cell Biol 1992; 70: 729-37.
55. Tang-Chu W, Matsuda S, Yoshimura H, Kawabe T, Sanaka M. Ciliary neurotrophic factor prevents ischemia-induced learning disability and neuronal loss in gerbils. Neurosci Lett 1995; 1991: 55-8.
56. Tancredi V, Doreangelo G, Grassi F, Tarroni P, Palmeri G, Santoni A, Eusebi F. Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci Lett 1992; 146: 176-8.
57. Cowan WM. Neuronal death as a regulative mechanism in the control of cell number in the nervous system. In Rockstein M, ed. Development and aging of the nervous system. New York: Academic Press; 1973. p. 19-41.
58. Ferrer I, Tortosa A, Blanco R, Martín F, Serrano T, Planas A, et al. Naturally occurring cell death in the developing cortex of the rat. Evidence of apoptosis-associated internucleosomal DNA fragmentation. Neurosci Lett 1994; 182: 77-9.
59. Pérez-Polo JR, Foreman PJ, Jackson GR, Shan P, Taglialetela G, Thorpe LW, et al. Nerve growth factor and neuronal cell death. Mol Neurobiol 1990; 4: 57-91.
60. Ohsawa F, Widner HR, Knusel B, Denton TL, Hefti F. Response of embryonic rat hippocampal neurons in culture to neurotrophin-3, brain neurotrophic derived factor and basic fibroblast growth factor. Neuroscience 1993; 57: 67-77.
61. Raff MC, Barres BA, Buine JF, Coles HS, Ishizaki Y, Jacobson MD. Programmed cell death and the control of cell survival: Lesson from the nervous system. Science 1993; 262: 695-700.
62. Korsching S. The neurotrophic factor concept: A reexamination. J Neurosci 1993; 13: 2739-48.
63. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci 1992; 15: 323-31.
64. Calamandrei G, Alleva E. Neuronal growth factors, neurotrophins and memory deficiency. Behav Brain Res 1995; 66: 129-32.
65. Metsis M, Timmusk T, Allikmets R, Saorma M, Parsson H. Regulatory elements and transcriptional regulation by testosterone and retinoic acid of the rat nerve growth factor receptor promoter. Gene 1992; 121: 247-54.
66. Lauder JM. Neurotransmitters as growth regulatory signals: Role of receptors and second mensengers. Trends Neurosci 1993; 16: 233-9.
67. Wenk GL, Markowska AL, Olton DS. Basal forebrain lesions and memory: Alterations in neurotensin, not acetylcholine, may cause amnesia. Behav Neurosci 1989; 103: 765-9.
68. Toledano A, Rodriguez-Arellano JJ, Gómez de Segura IA, de Miguel E, Martinez-Rodríguez R. Bowel resection and neurotensin treatment. Histochemical study of neurotensin-like and somatostatin-like immunoreactivities and receptor. Cell Molec Biol 1996; 42: 1145-58.
69. Unger JW, Mc Neill TH, Lapham LL, Hamill RW. Neuropeptides and neuropathology of the amygdala in Alzheimer's disease: Relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques. Brain Res 1988; 248: 293-302.
70. Gorlind A, Fowler CJ, Alafuzoff I, Winblad B, Cowburn RF. Neurotransmitter-mediated inhibition of post mortem human brain adenyl cyclase. J Neurol Tans 1992; 87: 113-24.
71. Owen A, Bird M. Acetylcholine as a regulator of neunte out-growth and motility in cultured embryonic mouse spinal cord. Neuroreport 1995; 6: 2269-72.
72. Murphy S, Simmons ML, Agullo L, García A, Feinstein DL, Galea E. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993; 16: 323-8.
73. He Y, Duyckaerts YHC, Delaère P, Piette F, Hauw JJ. Alzheimer lesions labelled with antiubiquitine antibodies. Comparison with other staining techniques. A study of 15 cases with graded intellectual status in ageing and Alzheimer's disease. Neuropathol App Neurobiol 1993; 19: 364-71.
74. Pericak-Vance M, Haines JL. Genetic susceptibility to Alzheimer disease. Trends Genetics 1995; 11: 504-8.
75. Corder EH, Saunders AM, Strittmatter WJ, Schemechel DE, Gaskell PC, Small GW, et al. Gender dose of apolipoprotein E type allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
76. Garofalo L, da Silva A, Cuello AC. Potentiation of nerve growth factor induced alterations in cholinergic fibre lenght and presinaptic terminal size in cortex of lesioned rats by the monosialoganglioside GM1. Neuroscience 1993; 57: 21-40.
77. Leeden RW. Biology of gangliosides: neuritogenic and neuronotrophic properties. J Neurosci Res 1984; 12: 147-59.
78. Rahmann H. Brain gangliosides and memory formation. Behav Brain Res 1995; 66: 105-16.
79. Heintz N. Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem Sci 1993; 18: 157-9.
80. Miquel J. An Integrated theory of aging as the result of mitochondrial-ADN mutation on differentiated cells. Arch Gereontol Geriatr 1991; 12: 99-117.
81. Smith MA, Sayre LM, Manmer V, Perry G. Radical ageing in Alzheimer's disease. Trends Neurosci 1995; 18: 172-6.
82. Osiewacz HD, Hermanns J. The role of mitochondrial DNA rearrangements in aging and human diseases. Aging Clin Exp Res 1992; 4: 273-86.
83. Fleming JE, Miquel J, Bensh KG. Age dependent changes in mitochondria. In Woodhead AD, Blacketh AD, Hollander A, eds. Molecular Biology in Aging. New York: Plenum Press; 1985. p. 143-6.
84. Lin FH, Lin R, Wisniewski HM, Hwang YW, Gundke-Iqbal I, Healy-Lovie G, et al. Detection of point mutations in codon 331 of mitochondrical NADH deshidrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 1992; 182: 238-46.
85. Coyle JT, Puttfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689-700.
86. Myhrer J. Animal models of Alzheimer's disease: Glutamatergic denervation as an alterative approach to cholinergic denervation. Neurosci Biobehav Rev 1993; 17: 195-202.
87. Fedorenko GM, Gusatinsky VN, Kanunsky II, Kondratyeva LA, Korzak VM. Changing of an isolated neurone ultrastructure during a prolonged impact of mediator. Neuroreport 1995; 6: 2325-32.
88. Mattson MP. Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol 1992; 27: 29-49.
89. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 1993; 16: 409-14.
90. Wu J, Anwyl R, Rowan MJ. β-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. Neuroreport 1995; 6: 2409-13.
91. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15: 259-64.
92. Imaizumi K, Iwata H, Yoshida S, Sun G, Okomura N, Shiosaka S. Coexistence of amyloid β-protein precursor and basic fibroblast growth factor in single cells of the rat parietal cortex hippocampus and basal magnocellular nucleus. J Chem Neuroanat 1993; 6: 159-65.
93. Toledano A. Modelos animales para el estudio de la enfermedad de Alzheimer: aportaciones al conocimiento de la etiopatogenia y la terapeútica. Ann Real Acad Farm 1992; 58: 7-16.
94. Valsecchi M, Palestini P, Chigamo V, Sonnino S. Age-related changes of the ganglioside long-chain base composition in rat cerebellum. Neurochem Int 1996; 28: 183-7.
95. Vermersh P, Frigard B, Delacourte A. Mapping of neurofibrillary degeneration in Alzheimer's disease. Evaluation of heterogeneity using the cuantification of abnormal Tau proteins. Acta Neuropathol 1992; 85: 48-54.
96. Yamaguchi H, Yamakazi T, Ishiguro K, Shoji M, Nokazato Y, Hirai S. Ultrastructural localization of Alzheimer amyloid-beta/A4 protein precursor in the cytoplasm of neurons and senile plaques-associated astrocytes. Acta Neuropathol 1992; 85: 15-22.
97. Rapoport SI. Brain evolution and Alzheimer disease. Rev Neurol 1988; 144: 79-90.
98. Toledano A. Enfermedad de Alzheimer: hipótesis actuales. En López-Ibor J, Sainz-Ruiz J, eds. Actas del Congreso Nacional de la Sociedad de Psiquiatría Biológica. Madrid: Aran Ediciones; 1989. p. 669-92.
99. Toledano A. Nuevos conceptos y nuevos abordajes terapéuticos, fundamentos para combatir la enfermedad de Alzheimer. An Real Acad Farm 1996; LXII: 717-65.